These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28964673)

  • 41. Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study.
    Goderis G; Vaes B; Van den Akker M; Elli S; Mathieu C; Buntinx F; Henrard S
    Prim Care Diabetes; 2017 Oct; 11(5):482-489. PubMed ID: 28648964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    Quigley M; Earnest A; Szwarcbard N; Wischer N; Andrikopoulos S; Green S; Zoungas S
    PLoS One; 2022; 17(2):e0263511. PubMed ID: 35120182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study.
    Lin E; Garmo H; Van Hemelrijck M; Adolfsson J; Stattin P; Zethelius B; Crawley D
    BMC Cancer; 2021 Nov; 21(1):1259. PubMed ID: 34809595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type 2 diabetes care in North Karelia Finland: do area-level socio-economic factors affect processes and outcomes?
    Sikiö M; Tykkyläinen M; Tirkkonen H; Kekäläinen P; Dunbar J; Laatikainen T
    Diabetes Res Clin Pract; 2014 Dec; 106(3):496-503. PubMed ID: 25451893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial.
    Edelman D; Fredrickson SK; Melnyk SD; Coffman CJ; Jeffreys AS; Datta S; Jackson GL; Harris AC; Hamilton NS; Stewart H; Stein J; Weinberger M
    Ann Intern Med; 2010 Jun; 152(11):689-96. PubMed ID: 20513826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.
    Wayne N; Perez DF; Kaplan DM; Ritvo P
    J Med Internet Res; 2015 Oct; 17(10):e224. PubMed ID: 26441467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Swedish National Survey of the Quality and Organization of Diabetes Care in Primary Healthcare--Swed-QOP.
    Adolfsson ET; Rosenblad A; Wikblad K
    Prim Care Diabetes; 2010 Jul; 4(2):91-7. PubMed ID: 20434973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flash Glucose Monitoring Improves Glucose Control in People with Type 2 Diabetes Mellitus Receiving Anti-diabetic Drug Medication.
    Chen M; Li H; Shen Y; Liu B; Yan R; Sun X; Ye L; Lee KO; Ma J; Su X
    Exp Clin Endocrinol Diabetes; 2021 Dec; 129(12):857-863. PubMed ID: 32858752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres.
    Sundquist K; Chaikiat A; León VR; Johansson SE; Sundquist J
    Diabetes Metab Res Rev; 2011 Mar; 27(3):244-54. PubMed ID: 21309045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?
    Foley JE; Bhosekar V; Kawamori R
    Vasc Health Risk Manag; 2016; 12():9-12. PubMed ID: 26855580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme.
    Musacchio N; Lovagnini Scher A; Giancaterini A; Pessina L; Salis G; Schivalocchi F; Nicolucci A; Pellegrini F; Rossi MC
    Diabet Med; 2011 Jun; 28(6):724-30. PubMed ID: 21294769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indigenous health worker support for patients with poorly controlled type 2 diabetes: study protocol for a cluster randomised controlled trial of the Mana Tū programme.
    Selak V; Stewart T; Jiang Y; Reid J; Tane T; Carswell P; Harwood M
    BMJ Open; 2018 Dec; 8(12):e019572. PubMed ID: 30552239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetes mellitus in Irish general practice: level of care as reflected by HbA1c values.
    O'Connor R; Houghton F; Saunders J; Dobbs F
    Eur J Gen Pract; 2006; 12(2):58-65. PubMed ID: 16945878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using collaborative learning to improve diabetes care and outcomes: the VIDA project.
    Barceló A; Cafiero E; de Boer M; Mesa AE; Lopez MG; Jiménez RA; Esqueda AL; Martinez JA; Holguin EM; Meiners M; Bonfil GM; Ramirez SN; Flores EP; Robles S
    Prim Care Diabetes; 2010 Oct; 4(3):145-53. PubMed ID: 20478753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of the Model of Care on the Outcomes of Diabetes Self-Management Education Program: A Scoping Review.
    Kumah E; Afriyie EK; Abuosi AA; Ankomah SE; Fusheini A; Otchere G
    J Diabetes Res; 2021; 2021():2969243. PubMed ID: 33688505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A collaborative care team to integrate behavioral health care and treatment of poorly-controlled type 2 diabetes in an urban safety net primary care clinic.
    Chwastiak LA; Jackson SL; Russo J; DeKeyser P; Kiefer M; Belyeu B; Mertens K; Chew L; Lin E
    Gen Hosp Psychiatry; 2017; 44():10-15. PubMed ID: 28041570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.